Dose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of Lymphoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Lymphoma · Waldenström Macroglobulinemia (WM) · DLBCL - Diffuse Large B Cell Lymphoma · PMBCL · HGBCL · FL Lymphoma · Lymphoplasmacytic Lymphoma · Follicular Lymphoma (FL)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Epworth HealthCare, Richmond, Victoria, Australia

    Contact: Study coordinator (ModeX Therapeutics) · info@modextx.com · +1 857-233-9936
    Contact: Principal Investigator (Dr. Costas Yannakou)
  • Linear Clinical Research, Nedlands, Western Australia, Australia

    Contact: Study coordinator (ModeX Therapeutics) · info@modextx.com · +1 857-233-9936
    Contact: Principal Investigator (Dr. Chan Cheah)